BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 37199043)

  • 21. Interferon-Induced Bone Marrow Stromal Antigen 2 (BST2) Is A Functional Tumor-Initiating Cell Marker In Triple-Negative Breast Cancer.
    Souto EP; Gong P; Landua JD; Srinivasan RR; Ganesan A; Dobrolecki LE; Purdy SC; Ford HL; Lewis MT
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of computed tomography scan-assessed body composition with immune and PI3K/AKT pathway proteins in distinct breast cancer tumor components.
    Cheng TD; Fu DA; Falzarano SM; Zhang R; Datta S; Zhang W; Omilian AR; Aduse-Poku L; Bian J; Irianto J; Asirvatham JR; Campbell-Thompson M
    medRxiv; 2024 May; ():. PubMed ID: 38826360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
    Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
    Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Signal transducer and activator of transcription 3 and cancer associated fibroblasts jointly generate chemo-resistance and affect prognosis in epithelial ovarian cancer].
    Zhang YN; Li B; Li YQ; Liu SH; Hou HY; Wang KY; Ao M; Song Y
    Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):368-377. PubMed ID: 37217344
    [No Abstract]   [Full Text] [Related]  

  • 25. Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer.
    Wang F; Long J; Li L; Wu ZX; Da TT; Wang XQ; Huang C; Jiang YH; Yao XQ; Ma HQ; Lian ZX; Zhao ZB; Cao J
    Sci Adv; 2023 Jun; 9(24):eadf5464. PubMed ID: 37327339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activin A-Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer.
    Pich-Bavastro C; Yerly L; Di Domizio J; Tissot-Renaud S; Gilliet M; Kuonen F
    Clin Cancer Res; 2023 Sep; 29(17):3498-3513. PubMed ID: 37327314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
    Wang D; Keyoumu K; Yu R; Wen D; Jiang H; Liu X; Di X; Zhang S
    Mol Med; 2024 May; 30(1):61. PubMed ID: 38760717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplex Digital Spatial Profiling in Breast Cancer Research: State-of-the-Art Technologies and Applications across the Translational Science Spectrum.
    Rossi M; Radisky DC
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer.
    Long L; Fei X; Chen L; Yao L; Lei X
    Front Oncol; 2024; 14():1381251. PubMed ID: 38699644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer.
    Nederlof I; Horlings HM; Curtis C; Kok M
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.
    Morrow E; Pennel K; Hatthakarnkul P; Leslie H; Mallon E; Andersen D; Jamieson N; McMillan D; Roseweir A; Edwards J
    Cancer Med; 2023 Jun; 12(12):13225-13240. PubMed ID: 37199043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
    Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J
    J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
    Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
    Shamis SA; Savioli F; Ammar A; Al-Badran SS; Hatthakarnkul P; Leslie H; Mallon EE; Jamieson NB; McMillan DC; Edwards J
    Histol Histopathol; 2024 Feb; 39(2):177-200. PubMed ID: 37681672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of TLR3 in triple-negative breast cancer predicts better prognosis-data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays.
    Fan L; Sui XY; Jin X; Zhang WJ; Zhou P; Shao ZM
    BMC Cancer; 2023 Apr; 23(1):298. PubMed ID: 37005579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
    Mumin NH; Drobnitzky N; Patel A; Lourenco LM; Cahill FF; Jiang Y; Kong A; Ryan AJ
    BMC Cancer; 2019 Jan; 19(1):102. PubMed ID: 30678647
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.